𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessment of CYP2D6 activity in depressed patients

✍ Scribed by M. Szewczuk-Bogusawska; K. Orzechowska-Juzwenko; P. Milejski; J.A. Beszej; M. Grzesiak; A. Kiejna

Book ID
119576004
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
118 KB
Volume
12
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clomipramine, fluoxetine and CYP2D6 meta
Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients
✍ P. Vandel; E. Haffen; S. Nezelof; F. Broly; J. P. Kantelip; D. Sechter πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 67 KB

## Abstract Cytochrome P450‐2D6 may be involved in the metabolism of many drugs such as psychotropic drugs and its genetic polymorphism is responsible for inter‐individual differences in the therapeutic effect and toxicity of these drugs. Moreover with the same genetic basis, CYP2D6 metabolic capac

CYP2D6 genotype and venlafaxine-XR conce
CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly
✍ Ellen M. Whyte; Marjorie Romkes; Benoit H. Mulsant; Margaret A. Kirshne; Amy E. πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract ## Introduction The elderly are at increased risk for medication‐related adverse events. Recent reports indicate that venlafaxine may put the elderly at increased risk of cardio‐ and cerebrovascular adverse events. We investigated the relationship between the __CYP2D6__ polymorphism an